PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function

Summary

The primary objective of this study is to evaluate the potential effect of renal impairment on the systemic pharmacokinetics of acute Intranasal RX0041-002. The secondary objective is to evaluate the safety and tolerability of acute Intranasal RX0041-002 in subjects with normal renal function and severe renal impairment.

Timeline

Start

2016-02

Primary completion

2016-07

Completion

2016-10

Drugs

Indications

No indication recorded.